Furthermore, the biomarker panel’s performance in discriminating LUTS/BPH from patients with more aggressive PCa, Gleason (≥ 8), was also determined to be significantly improved compared to PSA alone (AUC 0.74 vs. 0.47; Fig. 4B). Here, KLK3 is linked to posterior cortical atrophy.